Related Experiment Video
Updated: May 28, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4
Johannes Backs1, Barbara C Worst, Lorenz H Lehmann
1Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany. johannes.backs@med.uni-heidelberg.de
Insights
Protein kinase A (PKA) counters cardiac hypertrophy by cleaving Histone deacetylase 4 (HDAC4), generating a fragment that inhibits myocyte enhancer factor 2 (MEF2) activity and opposes calcium/calmodulin-dependent protein kinase II (CaMKII) signaling.
Area of Science:
- Molecular biology
- Cardiovascular research
- Cell signaling
Background:
- Histone deacetylase 4 (HDAC4) is a key regulator of gene expression, notably repressing myocyte enhancer factor 2 (MEF2) and serum response factor (SRF).
- Calcium/calmodulin-dependent protein kinase II (CaMKII) signaling in cardiomyocytes promotes hypertrophy and pathological remodeling, partly via HDAC4 phosphorylation and subsequent MEF2 activation.
Purpose of the Study:
- To elucidate a novel mechanism by which protein kinase A (PKA) antagonizes CaMKII-driven prohypertrophic signaling in cardiomyocytes.
- To investigate the role of HDAC4 proteolysis in mediating the opposing effects of PKA and CaMKII pathways.
Main Methods:
- Investigated the interaction between PKA, CaMKII, and HDAC4 in cardiomyocyte signaling.
- Analyzed the generation and function of an N-terminal HDAC4 cleavage product (HDAC4-NT).
- Assessed the impact of HDAC4-NT on MEF2 and SRF transcription factor activity and cardiomyocyte hypertrophy.
Main Results:
- PKA signaling induces regulated proteolysis of HDAC4, generating an N-terminal fragment (HDAC4-NT).
- HDAC4-NT selectively inhibits MEF2 activity, thereby counteracting the prohypertrophic effects of CaMKII.
- This PKA-mediated mechanism antagonizes CaMKII's prohypertrophic actions without compromising cardiomyocyte survival.
Conclusions:
- HDAC4 acts as a molecular nexus integrating antagonistic PKA and CaMKII signaling pathways in cardiomyocytes.
- Regulated proteolysis of HDAC4 by PKA offers a novel mechanism for controlling MEF2 activity and preventing pathological cardiac remodeling.
- These findings provide insights into the molecular basis of cardioprotection and cellular processes involving opposing kinase signaling.
Abstract:
Histone deacetylase 4 (HDAC4) regulates numerous gene expression programs through its signal-dependent repression of myocyte enhancer factor 2 (MEF2) and serum response factor (SRF) transcription factors. In cardiomyocytes, calcium/calmodulin-dependent protein kinase II (CaMKII) signaling promotes hypertrophy and pathological remodeling, at least in part by phosphorylating HDAC4, with consequent stimulation of MEF2 activity. In this paper, we describe a novel mechanism whereby protein kinase A (PKA) overcomes CaMKII-mediated activation of MEF2 by regulated proteolysis of HDAC4. PKA induces the generation of an N-terminal HDAC4 cleavage product (HDAC4-NT). HDAC4-NT selectively inhibits activity of MEF2 but not SRF, thereby antagonizing the prohypertrophic actions of CaMKII signaling without affecting cardiomyocyte survival. Thus, HDAC4 functions as a molecular nexus for the antagonistic actions of the CaMKII and PKA pathways. These findings have implications for understanding the molecular basis of cardioprotection and other cellular processes in which CaMKII and PKA exert opposing effects.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

